DXR

$0.00

(

+0.00%

)
Quote details

stock

Daxor Corporation

NASDAQ | DXR

13.54

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 21, 2025)

$66.19M

Market Cap

83

P/E Ratio

0.16

EPS

$14.00

52 Week High

$6.55

52 Week Low

HEALTHCARE

Sector

DXR Chart

Recent Chart
Price Action

DXR Technicals

Tags:

DXR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.1M
Total Revenue $2.1M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $621K
Selling General And Administrative $294K
Research And Development -
Operating Expenses $1.6M
Investment Income Net -
Net Interest Income -$85K
Interest Income $0
Interest Expense $85K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.4M
Income Before Tax $536K
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $536K
Comprehensive Income Net Of Tax -
Ebit -$815K
Ebitda $621K
Net Income $536K

Revenue & Profitability

Earnings Performance

DXR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $37M
Total Current Assets $19K
Cash And Cash Equivalents At Carrying Value -
Cash And Short Term Investments -
Inventory -
Current Net Receivables $9.7K
Total Non Current Assets $37M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $37M
Short Term Investments -
Other Current Assets $8.9K
Other Non Current Assets -
Total Liabilities $840K
Total Current Liabilities $110K
Current Accounts Payable $110K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $730K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $730K
Other Current Liabilities -
Other Non Current Liabilities -
Total Shareholder Equity $36M
Treasury Stock -
Retained Earnings $26M
Common Stock $54K
Common Stock Shares Outstanding $4.8M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $26K
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $4
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $1.9M
Cashflow From Financing -$26K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $536K

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.1M
Total Revenue $2.1M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $621K
Selling General And Administrative $294K
Research And Development -
Operating Expenses $1.6M
Investment Income Net -
Net Interest Income -$85K
Interest Income $0
Interest Expense $85K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.4M
Income Before Tax $536K
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $536K
Comprehensive Income Net Of Tax -
Ebit -$815K
Ebitda $621K
Net Income $536K

Dividends

Field Value
Ex Dividend Date 2018-01-05
Declaration Date None
Record Date None
Payment Date None
Amount 0.03

DXR News

DXR Profile

Daxor Corporation Profile

Sector: HEALTHCARE

Industry: MEDICAL INSTRUMENTS & SUPPLIES

Daxor Corporation (DXR) is a pioneering medical device company headquartered in New York, dedicated to revolutionizing patient care through advanced blood volume monitoring technology. Specializing in cryobank and biotechnology services, Daxor's innovative solutions are designed to transform blood management practices within healthcare facilities across the United States. With a strong emphasis on improving health outcomes, Daxor leverages its proprietary technologies and cutting-edge research to position itself as a leader in the medical innovation landscape.

BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
HAL
+11.53%
$25.23
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
GRAB
+0.53%
$5.67
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.02%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
RGTZ
+15.11%
$15.61
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
WTO
+2.93%
$0.06
BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
HAL
+11.53%
$25.23
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
GRAB
+0.53%
$5.67
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.02%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
RGTZ
+15.11%
$15.61
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
WTO
+2.93%
$0.06

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.